Joshua W. Devine

422 total citations
23 papers, 302 citations indexed

About

Joshua W. Devine is a scholar working on Economics and Econometrics, Family Practice and Geriatrics and Gerontology. According to data from OpenAlex, Joshua W. Devine has authored 23 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 6 papers in Family Practice and 6 papers in Geriatrics and Gerontology. Recurrent topics in Joshua W. Devine's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (7 papers) and Medication Adherence and Compliance (6 papers). Joshua W. Devine is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (7 papers) and Medication Adherence and Compliance (6 papers). Joshua W. Devine collaborates with scholars based in United States and Canada. Joshua W. Devine's co-authors include Joel F. Farley, Carolyn Harley, Andrea Linton, Ronald S. Hadsall, Thomas A. Bacon, Eugene Moore, Katie J. Suda, Richard R. Cline, Inmaculada Hernandez and Walid F. Gellad and has published in prestigious journals such as JAMA, Osteoporosis International and JAMA Network Open.

In The Last Decade

Joshua W. Devine

19 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua W. Devine United States 8 89 57 44 41 40 23 302
Ângela Jornada Ben Netherlands 12 80 0.9× 29 0.5× 34 0.8× 68 1.7× 51 1.3× 31 384
Orysya Soroka United States 11 51 0.6× 61 1.1× 42 1.0× 22 0.5× 50 1.3× 38 540
Ryan P. Hickson United States 11 57 0.6× 33 0.6× 67 1.5× 87 2.1× 32 0.8× 18 330
Jonathan Underhill United Kingdom 9 63 0.7× 24 0.4× 50 1.1× 22 0.5× 41 1.0× 25 306
Youngsoo Shin South Korea 10 61 0.7× 68 1.2× 37 0.8× 49 1.2× 52 1.3× 24 387
Elizabeth Mackay Canada 8 110 1.2× 59 1.0× 42 1.0× 61 1.5× 19 0.5× 11 338
Sarah O’Brien United Kingdom 11 43 0.5× 59 1.0× 36 0.8× 17 0.4× 77 1.9× 23 365
Matthew Alcusky United States 13 79 0.9× 88 1.5× 64 1.5× 25 0.6× 36 0.9× 49 446
Michaël Gagnon United States 10 29 0.3× 53 0.9× 39 0.9× 23 0.6× 42 1.1× 15 318
Sergio Fernández‐Bertolín Spain 13 87 1.0× 196 3.4× 111 2.5× 26 0.6× 20 0.5× 21 447

Countries citing papers authored by Joshua W. Devine

Since Specialization
Citations

This map shows the geographic impact of Joshua W. Devine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua W. Devine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua W. Devine more than expected).

Fields of papers citing papers by Joshua W. Devine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua W. Devine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua W. Devine. The network helps show where Joshua W. Devine may publish in the future.

Co-authorship network of co-authors of Joshua W. Devine

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua W. Devine. A scholar is included among the top collaborators of Joshua W. Devine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua W. Devine. Joshua W. Devine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Devine, Joshua W., et al.. (2025). Hospital Accreditation and Geographic Disparities in Timely Cancer Care. Health Services Research. 61(2). e14655–e14655.
3.
4.
Tadrous, Mina, Inmaculada Hernandez, Joshua W. Devine, et al.. (2024). Differences in Drug Shortages in the US and Canada. JAMA. 332(22). 1912–1912. 4 indexed citations
5.
Devine, Joshua W., Mina Tadrous, Inmaculada Hernandez, et al.. (2023). A Retrospective Cohort Study of the 2018 Angiotensin Receptor Blocker Recalls and Subsequent Drug Shortages in Patients With Hypertension. Journal of the American Heart Association. 13(1). e032266–e032266. 3 indexed citations
6.
Devine, Joshua W., et al.. (2023). Prevalence and patterns of catastrophic spending for antidiabetic medication in 2020. Journal of Managed Care & Specialty Pharmacy. 29(10). 1158–1164.
7.
Devine, Joshua W., et al.. (2013). Automated Profile Review for Transdermal Fentanyl to Verify Opioid Tolerance in the Military Health System. Military Medicine. 178(11). 1241–1244. 2 indexed citations
8.
Devine, Joshua W., et al.. (2011). PUK4 CUMULATIVE EXPOSURE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND THE PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD). Value in Health. 14(3). A74–A75. 7 indexed citations
9.
Devine, Joshua W., et al.. (2011). A retrospective analysis of extended-interval dosing and the impact on bisphosphonate compliance in the US Military Health System. Osteoporosis International. 23(4). 1415–1424. 17 indexed citations
11.
Linton, Andrea, et al.. (2010). Results from a Mailed Promotion of Medication Reviews Among Department of Defense Beneficiaries Receiving 10 or More Chronic Medications. Journal of Managed Care Pharmacy. 16(8). 578–592. 12 indexed citations
12.
Devine, Joshua W., et al.. (2009). Formulary Management in the Department of Defense. Journal of Managed Care Pharmacy. 15(2). 133–146. 19 indexed citations
13.
Devine, Joshua W., et al.. (2009). Increase in lipid‐lowering treatment rates among TRICARE beneficiaries: a population‐based study. Pharmacoepidemiology and Drug Safety. 18(10). 891–899. 5 indexed citations
14.
Devine, Joshua W., et al.. (2007). Effect of daily migraine prevention on health care utilisation in an insured patient population. The Journal of Headache and Pain. 8(2). 105–113. 7 indexed citations
15.
Farley, Joel F., Joshua W. Devine, & Ronald S. Hadsall. (2007). Professional implications of the expansion of pharmacy-based medical clinics. Journal of the American Pharmacists Association. 47(3). 410–415. 4 indexed citations
16.
Farley, Joel F., Carolyn Harley, & Joshua W. Devine. (2006). A comparison of comorbidity measurements to predict healthcare expenditures.. PubMed. 12(2). 110–9. 160 indexed citations
17.
Devine, Joshua W., Richard R. Cline, & Joel F. Farley. (2006). Follow-on Biologics: Competition in the Biopharmaceutical Marketplace. Journal of the American Pharmacists Association. 46(2). 193–204. 5 indexed citations
18.
Devine, Joshua W., Joel F. Farley, & Ronald S. Hadsall. (2005). Patterns and Predictors of Prescription Medication Use in the Management of Headache: Findings From the 2000 Medical Expenditure Panel Survey. Headache The Journal of Head and Face Pain. 45(9). 1171–1180. 20 indexed citations
19.
Farley, Joel F., Carolyn Harley, & Joshua W. Devine. (2005). A Comparison of Comorbidity Measurements to Control for Confounding in Health Outcomes Studies. Defense Technical Information Center (DTIC). 2 indexed citations
20.
Devine, Joshua W.. (2003). A review of scrub typhus management in 2000-2001 and implications for soldiers.. 2. 14–20. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026